Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(100.0%)

6Total

N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06473766Not ApplicableRecruiting

Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses

Role: collaborator

NCT06111859Not ApplicableUnknown

Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification

Role: collaborator

NCT04462562Not ApplicableCompleted

Quantitative US for Evaluation of Hepatic Steatosis in NAFLD

Role: collaborator

NCT04180631Not ApplicableCompleted

Quantitative US for Hepatic Steatosis

Role: collaborator

NCT04985188Unknown

Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter Study

Role: collaborator

NCT03706534Not ApplicableUnknown

Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms

Role: lead

NCT03047707Not ApplicableCompleted

S-Shearwave Elastography for Assessment of Hepatic Fibrosis

Role: collaborator

All 7 trials loaded